Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator.
New regulation offers patients in Brazil greater access to experimental drugs.
Pharma eyes biologics production in Brazil as the government begins to recognize the potential of these drugs.
Brazil offers opportunities and challenges for global pharmaceutical companies.
Prior to price escalation of pharmaceutical products in Brazil, the country's regulatory authority released a study on price-cap control and its benefits in the past years.
Brazil's major vaccine producer innovates with stem-cell research.
Brazil to locally produce HIV/AIDS antiretroviral drug atazanavir.
Brazil's regulatory health authority, Anvisa, plans to establish quality requirements for locally produced pharmaceutical excipients, Anvisa told BioPharm International.